Search

Cardiovascular Disease Program pursues the promise of cardiac stem cells

Page

HSCI researchers’ discoveries shed light on cardiac development Cardiovascular disease is the leading cause of death in the world, impacts the lives of more than 71 million Americans, and costs society between $400 and $500 billion annually. There is a...

Cardiovascular Program

Page

The HSCI Cardiovascular Program aims to generate new human heart cells that can replace damaged heart tissue. The heart was long assumed to have little ability to regenerate on its own. In recent years, many research groups, including several in HSCI...

2012 HSCI call for proposals – Cardiovascular Program pilot grants

News

Application deadline: Thursday, May 3, 2012 The Harvard Stem Cell Institute (HSCI) Cardiovascular Program invites applications for Pilot Grants for 2012. The purpose of this funding program is to provide resources for research in cardiovascular disease...

Heart Disease

Page

The Harvard Stem Cell Institute is developing new techniques to grow and transplant heart cells, replacing those lost to cardiovascular disease. The greatest threat to the long-term health and well-being of people living with diabetes is cardiovascular...

Public forum: Stem cells and key diseases

Page

HSCI researchers are exploring options to treat diabetes, nervous system diseases, cardiovascular disease, and other degenerative diseases in a variety of ways, including stimulating existing stem cells, transplanting new cells, and targeting specific...

When Cell Therapy isn't Enough: Building Cardiovascular Solutions in 2016

Events

Guest speaker: Doris A. Taylor Director, Regenerative Medicine Research and Director, Center for Cell and Organ Biotechnology Texas Heart Institute This event is free and open to the public. Heart disease is the number-one killer of Americans, claiming...

HSCI Think Tanks: Accelerating the process of discovery

Page

The power of an international colloquium of pre-eminent scientists can be transformative. Nowhere was that more evident than in the three recent HSCI Think Tanks convened by Jeffrey Macklis, MD, DHST, head of HSCI’s Nervous System Diseases Program and...

Call for Proposals: 2022 HSCI Cardiovascular Program Translational Pilot Grant

News

AWARD AMOUNT Up to $50,000 for one year project period POSTED DATE Monday, December 6, 2021 DEADLINE FOR APPLICATION Friday, February 11, 2022 ANTICIPATED AWARD DATE Friday, April 1, 2022 The Harvard Stem Cell Institute (HSCI) Cardiovascular (CV) Program...

Seed Grants 2008

Page

Program Lead Affiliation Title Disease Area Paola Arlotta, PhD Harvard University Department of Stem Cell and Regenerative Biology Directed differentiation of neural progenitors and iPS Cells into corticospinal motor neurons Nervous System Disease...

Calum MacRae, M.D., Ph.D.

Person

The MacRae lab is focused on understanding the genetic contribution to common cardiovascular disease using human studies and complementary high-throughput biology in the zebrafish.

Our lab is interested in the role of functional inputs such as mechanical...

Caroline E. Burns, PhD

Person

Research in the Burns Lab focuses on cardiovascular development and regeneration.

Cardiovascular diseases represent the number one cause of morbidity and mortality worldwide, affecting a broad spectrum of ages from babies that are born with congenital...

Richard Lee, M.D.

Person

Richard T. Lee's laboratory seeks to understand heart failure and metabolic diseases that accompany human aging, and to translate that understanding into therapies, including stem cell transplantation strategies and new biological agents.

The Lee...